Dibutyl squarate
Suppliers
Names
[ CAS No. ]:
2892-62-8
[ Name ]:
Dibutyl squarate
[Synonym ]:
MFCD00037150
3,4-di-n-Butoxy-3-cyclobutene-1,2-dione
3,4-Dibutoxy-3-cyclobutene-1,2-dione
squaric acid dibutyl ester
Squaric acid di-n-butyl ester
SADBE
3-Cyclobutene-1,2-dione, 3,4-dibutoxy-
Di-n-butyl squarate
1,2-dibutyl squarate
dibutylsquarate
1,2-dibutoxy-1-cyclobutene-3,4-dione
Dibutyl squarate
3,4-dibutoxycyclobut-3-ene-1,2-dione
3,4-di-n-butyl-3-cyclobutene-1,2-dione
Squaric acid dibutylester
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
353.2±0.0 °C at 760 mmHg
[ Molecular Formula ]:
C12H18O4
[ Molecular Weight ]:
226.269
[ Flash Point ]:
157.2±30.7 °C
[ Exact Mass ]:
226.120514
[ PSA ]:
52.60000
[ LogP ]:
1.97
[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C
[ Index of Refraction ]:
1.477
[ Water Solubility ]:
INSOLUBLE
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H317-H319-H335
[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338
[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Hazard Codes ]:
Xn:Harmful;
[ Risk Phrases ]:
R36/37/38;R42/43
[ Safety Phrases ]:
S26-S27-S36/37/39-S45
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
GU1772066
[ HS Code ]:
2914509090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2914509090
[ Summary ]:
HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%
Articles
Journal. of. Drugs in. Dermatology. 11(10) , 1228-30, (2012)
Squaric acid dibutyl ester (SADBE) is a commonly used treatment for verruca vulgaris of childhood. Few studies, however, have examined the role of SADBE in combination with other topical therapies for...
Bioorg. Med. Chem. Lett. 17(22) , 6151-4, (2007)
Vitronectin receptor (alpha(V)beta(3)) antagonists have been implicated as a possible new treatment of restenosis following balloon angioplasty. In this work we investigate a series of novel arginine ...
Clin. Exp. Immunol. 135(3) , 398-408, (2004)
The acute phase of alopecia areata (AA) is characterized by an increase in CD44v3+ and CD44v10+ skin-infiltrating leucocytes (SkIL). Induction of a contact eczema, one of the therapeutic options in AA...